Back
CVE-2026-19731
Path Traversal in TÜBİTAK BİLGEM's İmzager
Low3.3EPSS 0.13%
- Published
- Updated
- Reserved
- Assigned by
- TR-CERT
Description
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute İmzager allows Path Traversal. This issue affects İmzager: from 2.10.5 before 2.10.7.
Scores
| Scored by | CVSS | Score | Vector |
|---|---|---|---|
| TR-CERTCNA (assigner) | 3.1 | Low3.3 | CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N |
| NVDNVD · Deferred | 3.1 | Low3.3 | CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N |
- EPSS (exploitation in 30 days)
- 0.13% · top 98% of all CVEs (7 Nov 2026)
Loading the EPSS history…
The list uses the assigner's score when there is one, then CISA's, then NVD's: Low 3.3.
Weakness
Affected products
TÜBİTAK BİLGEM Software Technologies Research Institute · İmzager
- affected 2.10.5 – < 2.10.7
References (1)
Sources
The same CVE in the primary databases and aggregators, to check against.
- CVE.org record (opens in a new tab)
- CVE List JSON (GitHub) (opens in a new tab)
- NVD (opens in a new tab)
- FIRST EPSS (opens in a new tab)
- OSV.dev (opens in a new tab)
- GitHub Advisories (opens in a new tab)
- CIRCL Vulnerability-Lookup (opens in a new tab)
Badge for a README or a ticket
[](https://trackcve.app/cve/CVE-2026-19731)Record last updated .